Valuation : Harbin Pharmaceutical Group Co., Ltd.

Market Cap 21.53B 3.2B 2.76B 2.6B 2.37B 4.43B 303B 4.47B 30.83B 11.96B 155B 12.03B 11.77B 508B P/E 2026 *
35.6x
P/E 2027 * 30.5x
Enterprise Value 21.53B 3.2B 2.76B 2.6B 2.37B 4.43B 303B 4.47B 30.83B 11.96B 155B 12.03B 11.77B 508B EV / Sales 2026 *
1.31x
EV / Sales 2027 * 1.27x
Free-Float
47.74%
Yield 2026 *
-
Yield 2027 * -
1 day-2.63%
1 week+12.96%
Current month+1.32%
1 month+56.88%
3 months+177.48%
6 months+161.76%
Current year+167.83%
1 week 8.37
Extreme 8.37
9.51
1 month 5.93
Extreme 5.93
9.51
Current year 2.84
Extreme 2.84
9.51
1 year 2.84
Extreme 2.84
9.51
3 years 2.41
Extreme 2.41
9.51
5 years 2.41
Extreme 2.41
9.51
10 years 2.38
Extreme 2.38
9.77
Manager TitleAgeSince
Chief Executive Officer 64 27/12/2023
Director of Finance/CFO 54 24/12/2004
Investor Relations Contact 45 27/04/2022
Director TitleAgeSince
Director/Board Member 60 08/01/2021
Chairman 56 27/12/2023
Director/Board Member 46 27/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Sell 36,000 0.0014%
01/07/24 Sell 27,000 0.0011%
01/07/24 Sell

Chief Financial Officer

90,000 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-2.63%+12.96%+147.72%+185.19% 3.46B
-0.63%-1.92%+56.34%+106.66% 1,034B
+1.08%+4.54%+56.09%+72.92% 663B
-0.37%+0.91%+22.96%+78.31% 462B
+3.31%-1.98%+32.39%+38.48% 344B
+0.34%+5.49%+27.55%+47.68% 307B
+1.23%+0.18%-0.61%+13.53% 251B
-0.07%+1.31%+55.97%+74.30% 239B
-0.03%+2.13%-17.30%-53.99% 207B
+0.23%+0.64%+32.60%+99.33% 186B
Average +0.26%-0.07%+41.37%+66.24% 369.68B
Weighted average by Cap. +0.40%-0.83%+38.39%+68.12%

Financials

2026 *2027 *
Net sales 16.4B 2.44B 2.11B 1.98B 1.81B 3.38B 231B 3.4B 23.48B 9.11B 118B 9.17B 8.96B 387B 16.94B 2.52B 2.17B 2.05B 1.87B 3.49B 238B 3.51B 24.25B 9.41B 122B 9.46B 9.26B 400B
Net income 607M 90.28M 77.88M 73.37M 66.85M 125M 8.53B 126M 869M 337M 4.36B 339M 332M 14.32B 699M 104M 89.72M 84.52M 77M 144M 9.82B 145M 1B 388M 5.02B 391M 382M 16.5B
Net Debt - -
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
03/09/26 CN¥8.550 -7.47% 443,030,400
02/09/26 CN¥9.240 -2.63% 260,543,012
01/09/26 CN¥9.490 +4.06% 335,925,254
31/08/26 CN¥9.120 +1.33% 295,970,209
28/08/26 CN¥9.000 +2.86% 440,650,442
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.550CNY
Average target price
9.160CNY
Spread / Average Target
+7.13%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600664 Stock